肝纤维化

预约门诊

分期

医务人员通常根据肝中存在的瘢痕组织数量对肝纤维化进行分期。这些分期有助于估计瘢痕形成的严重程度，以及疾病随时间推移而加重的可能性。

肝纤维化通常使用 F0 至 F4 分期进行描述。

  • F0 指肝部没有瘢痕形成。
  • F1 指存在轻度瘢痕形成，但肝结构基本保持完整。
  • F2 指已经在肝内部开始出现中等程度的瘢痕形成。
  • F3 指晚期瘢痕形成，受累肝脏区域较大且血流被破坏。
  • F4 指肝硬化，这是严重程度最高的分期，瘢痕广泛存在并对肝脏造成持久性损伤。
申请预约
诊断与治疗医生与科室
June 04, 2026
  1. Sterling RK, et al. AASLD practice guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology. 2025; doi:0.1097/HEP.0000000000000845.
  2. Sterling RK, et al. AASLD practice guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology. 2025; doi:10.1097/HEP.0000000000000843.
  3. Somnay K, et al. Liver fibrosis leading to cirrhosis: Basic mechanisms and clinical perspectives. Biomedicines. 2024; doi:10.3390/biomedicines12102229.
  4. Lai JC, et al. Noninvasive tests for liver fibrosis in 2024: Are there different scales for different diseases? Gastroenterology Report. 2024; doi:10.1093/gastro/goae024.
  5. Zhao L, et al. Pharmacotherapy of liver fibrosis and hepatitis: Recent advances. Pharmaceuticals. 2024; doi:10.3390/ph17121724.
  6. Cerrito L, et al. Present and future perspectives in the treatment of liver fibrosis. Pharmaceuticals. 2025; doi:10.3390/ph18091321.
  7. Fibrosis (scarring). American Liver Foundation. https://liverfoundation.org/about-your-liver/how-liver-diseases-progress/fibrosis-scarring/. Accessed Jan. 30, 2026.
  8. Hepatic fibrosis. Merck Manual Professional Edition. https://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/fibrosis-and-cirrhosis/hepatic-fibrosis. Accessed Jan. 30, 2026.
  9. 13 ways to a healthy liver. American Liver Foundation. https://liverfoundation.org/resource-center/blog/healthy-liver-tips/. Accessed Jan. 30, 2026.
  10. Ami TR. Allscripts EPSi. Mayo Clinic. Nov. 23, 2022.
  11. Tacke F, et al. EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Journal of Hepatology. 2024; doi:10.1016/j.jhep.2024.04.031.

相关

相关医疗程序

肝纤维化